1. Home
  2. HY vs ANL Comparison

HY vs ANL Comparison

Compare HY & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyster-Yale Materials Handling Inc.

HY

Hyster-Yale Materials Handling Inc.

HOLD

Current Price

$37.71

Market Cap

640.3M

Sector

Industrials

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.33

Market Cap

731.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HY
ANL
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
640.3M
731.6M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
HY
ANL
Price
$37.71
$10.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
65.6K
132.6K
Earning Date
05-05-2026
04-10-2026
Dividend Yield
3.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,769,300,000.00
N/A
Revenue This Year
$1.37
$36.02
Revenue Next Year
$5.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.41
$0.88
52 Week High
$44.55
$17.25

Technical Indicators

Market Signals
Indicator
HY
ANL
Relative Strength Index (RSI) 58.48 42.48
Support Level $34.84 $6.92
Resistance Level $37.89 $12.59
Average True Range (ATR) 1.52 1.15
MACD 0.20 -0.09
Stochastic Oscillator 86.46 29.11

Price Performance

Historical Comparison
HY
ANL

About HY Hyster-Yale Materials Handling Inc.

Hyster Yale Inc designs, engineers, manufactures, sells, and services a comprehensive line of lift trucks, attachments, aftermarket parts, and technology solutions marketed globally under the Hyster and Yale brand names. The company has four segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni). The majority of its revenue is generated from Lift Trucks. Geographically, it operates in America, EMEA, and JAPIC regions, of which maximum revenue is generated from its business in America, which includes lift truck operations in the U.S., Canada, Mexico, Brazil, and Latin America.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: